Disclosures

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of The Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Mark Donowitz, MD, reports receiving honoraria from Sucampo Pharmaceuticals, Inc; holding stock in Tranzmembrane, Inc (holder of NHE3 patent); and serving on the scientific advisory board for Institute for One World Health.

Henry Parkman, MD, reports receiving grants/research support from Medtronic, Inc, SmartPill Corporation, and Tranzyme Pharma Inc; serving as a consultant for SmartPill Corporation and Tranzyme Pharma Inc; and serving on the speakers' bureau for SmartPill Corporation.

Adil Bharucha, MD, reports having no financial or advisory relationships with corporate organizations related to this activity.

Jonathan Kaunitz, MD, reports receiving grants/research support from Takeda Pharmaceuticals North America, Inc.

Satish Rao, MD, PhD, reports receiving grants/research support from SmartPill Corporation; serving as a consultant for Boehringer Ingelheim, Forest Laboratories, Inc, Proctor & Gamble, SmartPill Corporation, and Takeda Pharmaceuticals North America, Inc; and serving on the speakers' bureau for AstraZeneca, Sucampo Pharmaceuticals, Inc, and Takeda Pharmaceuticals North America, Inc.